174 related articles for article (PubMed ID: 6609130)
1. Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.
Pels E; De Weger RA; Den Otter W
Int Arch Allergy Appl Immunol; 1984; 74(2):140-6. PubMed ID: 6609130
[TBL] [Abstract][Full Text] [Related]
2. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte induced macrophage cytotoxicity: characterization of the macrophage cytotoxicity-inducing lymphocyte.
Pels E; de Weger RA; den Otter W
Immunobiology; 1984 Jan; 166(1):84-95. PubMed ID: 6201434
[TBL] [Abstract][Full Text] [Related]
4. Lymphokine-induced cytotoxicity: characterization of effectors, precursors, and regulatory ancillary cells.
Ting CC; Yang SS; Hargrove ME
Cancer Res; 1986 Feb; 46(2):513-8. PubMed ID: 3079663
[TBL] [Abstract][Full Text] [Related]
5. Two specific T cell factors that initiate immune responses in murine allograft systems. A comparison of biologic functions.
Vandebriel RJ; De Weger RA; Los G; Van Loveren H; Wiegers GJ; Oude Weernink PA; Den Otter W
J Immunol; 1989 Jul; 143(1):66-73. PubMed ID: 2659669
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.
Malkovský M; Asherson GL; Chandler P; Colizzi V; Watkins MC; Zembala M
J Immunol; 1983 Feb; 130(2):785-90. PubMed ID: 6217254
[TBL] [Abstract][Full Text] [Related]
7. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
[TBL] [Abstract][Full Text] [Related]
8. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
9. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.
Fujiwara H; Takai Y; Sakamoto K; Hamaoka T
J Immunol; 1985 Sep; 135(3):2187-91. PubMed ID: 3874911
[TBL] [Abstract][Full Text] [Related]
11. Lyt phenotype of H-2b CTL effectors and precursors specific for the SV40 transplantation rejection antigen.
Flyer DC; Anderson RW; Tevethia SS
J Immunol; 1982 Dec; 129(6):2368-71. PubMed ID: 6292288
[TBL] [Abstract][Full Text] [Related]
12. Effects of gamma-irradiation on lymphocyte subpopulations participating in the development of the cytotoxic T lymphocyte response.
Susskind BM; Faanes RB
J Immunol; 1981 Oct; 127(4):1485-9. PubMed ID: 6974194
[TBL] [Abstract][Full Text] [Related]
13. Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes.
Finke JH; Sharma SD; Scott JW
J Immunol; 1981 Dec; 127(6):2354-61. PubMed ID: 6795272
[TBL] [Abstract][Full Text] [Related]
14. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
15. The role of macrophages in the generation of T helper cells. III. Influence of macrophage-derived factors in helper cell induction.
Erb P; Feldmann M
Eur J Immunol; 1975 Nov; 5(11):759-66. PubMed ID: 1088716
[TBL] [Abstract][Full Text] [Related]
16. Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors.
Czitrom AA; Sunshine GH; Reme T; Ceredig R; Glasebrook AL; Kelso A; MacDonald HR
J Immunol; 1983 Feb; 130(2):546-50. PubMed ID: 6600241
[TBL] [Abstract][Full Text] [Related]
17. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
Sypek JP; Panosian CB; Wyler DJ
J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
Treves AJ; Schechter B; Cohen IR; Feldman M
J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
[TBL] [Abstract][Full Text] [Related]
19. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K
J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
